» Articles » PMID: 34694592

Association of Interleukin-10 Polymorphisms with Susceptibility to Colorectal Cancer and Gastric Cancer: an Updated Meta-analysis Based on 106 Studies

Overview
Publisher Springer
Date 2021 Oct 25
PMID 34694592
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to explore the association of IL-10 polymorphisms with susceptibility to colorectal cancer (CRC) and gastric cancer (GC).

Methods: PubMed, Scopus, Embase, SciELO, medRxiv, China Biology Medicine Disc, DeepDyve, CNKI, and Web of Science were used to identify all relevant articles published up to 20th June 2021, without any restrictions on ethnicity. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to determine the strength of the associations.

Results: A total of 106 case-control studies were included. For CRC, 15 studies with 2772 cases and 3719 controls on -1082A/G, 11 studies with 3259 cases and 4992 controls on -592C/A, and 3 studies with 477 cases and 544 controls on -819 T/C were selected. For GC, 31 studies with 6229 cases and 8666 controls on -1082A/G, 27 studies with 5457 cases and 8381 controls on -592C/A, and 19 studies with 3556 cases and 6218 controls on -819 T/C were included. Pooled data showed a significant association between IL-10-819 T/C polymorphism and CRC susceptibility in overall population, but not for IL-10-1082A/G and -592C/A polymorphisms. However, IL-10-592C/A polymorphism was associated with CRC risk in Asians. A significant association of IL-10-1082A/G polymorphism with the GC risk was found. In the ethnicity subgroup analysis, a significant association was found between IL-10-1082A/G polymorphism and GC risk among Asians. The IL-10-819 T/C was not associated with GC risk in overall population and by ethnicity.

Conclusions: Our pooled data show a significant association of IL-10-819 T/C and IL-10-1082A/G polymorphisms with CRC and GC in overall population, respectively. However, other factors may influence these associations, and large-scale studies with adequate methodological quality are necessary to confirm the impact on CRC and GC risk.

Citing Articles

Inactivation of glutathione -transferase alpha 4 blocks -induced bystander effect by promoting macrophage ferroptosis.

Ju Y, Ma C, Huang L, Tao Y, Li T, Li H Gut Microbes. 2025; 17(1):2451090.

PMID: 39819335 PMC: 11740687. DOI: 10.1080/19490976.2025.2451090.


A-Allele as a Biomarker for Periodontitis Severity in Bulgarian Patients.

Pashova-Tasseva Z, Dosseva-Panova V, Mlachkova A, Savov A, Tosheva E Genes (Basel). 2024; 15(9).

PMID: 39336814 PMC: 11431461. DOI: 10.3390/genes15091221.


Immunotherapy for colorectal cancer: insight from inherited genetics.

Tjader N, Toland A Trends Cancer. 2024; 10(5):444-456.

PMID: 38360438 PMC: 11096082. DOI: 10.1016/j.trecan.2024.01.008.

References
1.
Lyons K, Le L, Pham Y, Borron C, Park J, Tran C . Gastric cancer: epidemiology, biology, and prevention: a mini review. Eur J Cancer Prev. 2019; 28(5):397-412. DOI: 10.1097/CEJ.0000000000000480. View

2.
Antikchi M, Neamatzadeh H, Ghelmani Y, Jafari-Nedooshan J, Dastgheib S, Kargar S . The Risk and Prevalence of COVID-19 Infection in Colorectal Cancer Patients: a Systematic Review and Meta-analysis. J Gastrointest Cancer. 2020; 52(1):73-79. PMC: 7524641. DOI: 10.1007/s12029-020-00528-3. View

3.
Mannucci A, Zuppardo R, Rosati R, Di Leo M, Perea J, Cavestro G . Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis. World J Gastroenterol. 2019; 25(21):2565-2580. PMC: 6558439. DOI: 10.3748/wjg.v25.i21.2565. View

4.
Parsafar S, Hematti S, Ghorbani F, Safari F, Tavassoli M . Polymorphic GT dinucleotide repeat in the PIK3CA gene and risk of colorectal cancer. Cancer Biomark. 2015; 15(4):397-403. DOI: 10.3233/CBM-150487. View

5.
Wang X, Yang F, Xu G, Zhong S . The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: A meta-analysis. Cytokine. 2018; 111:230-236. DOI: 10.1016/j.cyto.2018.08.024. View